# Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)

> **NCT03740737** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 579 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Follitropin delta
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03740737
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-26
- **Primary completion:** 2020-11-11
- **Final completion:** 2020-11-11
- **Target enrollment:** 579 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03740737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03740737, "Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03740737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*